• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'breast cancer survival analysis'

Statisztikai híradó

Szakértői tevékenysége során részt vett az ENSZ Népesedési Alapja által finanszírozott és a Nemzetközi Munkaügyi Hivatal (ILO) szervezeti keretei között végzett

Protected

N/A

2
0
0
2022
Theprognosticsignificanceoftumour–stromaratioinoestrogenreceptor-positivebreastcancer SHORTCOMMUNICATION

Conclusions: High stromal content was related to better survival in ER-positive breast cancers across both genders, contrasting data in triple-negative breast cancer and

Protected

N/A

4
0
0
2022
Bevesszük a kanyart?
[Csath Magdolna: Bevesszük a kanyart? – Tudás-Érték-Jövő. Kairosz Kiadó, 2019, 231 oldal]

Ezeket (az alkalmazhatóság statisztikai módszerekkel történő vizsgálata után) használhatjuk a gazdasági szerkezet átalakulásának nyomon követésére, ugyanakkor ebben az

Protected

N/A

3
0
0
2022
Expression Levels as a Predictor of Response to Endocrine Therapy in ER + Breast Cancer

Additionally, a retrospective analysis evaluating ZNF217 expression levels in primary breast tumor of ER + /HER2 − /LN0 breast cancer patients treated with adjuvant ET enabled

Protected

N/A

6
0
0
2022
lnc00673 (ERRLR01) is a Prognostic Indicator ofOverall Survival in Breast Cancer

We analyzed Affymetrix U133 gene chip data, as well as the breast cancer TCGA dataset and determined that across four distinct breast cancer subtypes, as

Protected

N/A

21
0
0
2022
linc00673 (ERRLR01) is a prognostic indicator ofoverall survival in breast cancer

We analyzed Affymetrix U133 gene chip data, as well as the breast cancer TCGA data set and determined that across four distinct breast cancer subtypes, as determined by

Protected

N/A

14
0
0
2022
Effects of Abamectin on Two Spotted Spider Mite and Trichogramma brassicae and Efficacy of Its Residual Effects Applied on the Bean Plants

In present study 50% mite mortality was achieved with using 0.417 ppm of trade product (0.010 ppm of active ingredient) of abamectin which is about 8.4 times lower than dose used

Protected

N/A

8
0
0
2022
ÖSSZEFOGLALÓ REFERÁTUMOK

tis in early breast cancer patients: effects of systemic treatments. és mtsai: Conformal adjuvant radiotherapy in breast cancer. és mtsa: Specialisation and breast

Protected

N/A

6
0
0
2022
Az ösztrogénmetabolom biológiai és klinikai jelentősége lokális folyamatokban

Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast

Protected

N/A

9
0
0
2022
ARTICLE IN PRESS

mAb, Monoclonal antibody; MCF-7, Michigan Cancer Foundation-7 breast-cancer cell line; MDA-MB-231, Breast-cancer cell line; NSCLC, Non-small cell lung cancer; OEC- M1, Human

Protected

N/A

8
0
0
2022
Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients

We also studied prognostic value of S100P mRNA expression using the KM plotter which assessed the effect of 22,277 genes on survival in 2422 breast cancer patients.. Moreover,

Protected

N/A

12
0
0
2022
Comparative Constitutionalism in Central Europe – Summary

To provide a general overview on the constitutionalism of Central European Post-Socialist countries, the volume first goes through the constitutional history of the examined

Protected

N/A

7
0
0
2022
Gene expression based prognostic classification of  solid tumors

The topics are the gene expression based classification of colorectal cancer, new prognostic classification of breast cancer, prediction lymph node status of

Protected

N/A

14
0
0
2022
Torzó a XXX. századból

Anya biztosan megkérdi, hogy: „Ugye nem ittál, kisfiam?" Ö mondhatja, hogy nem ivott, mert ma tényleg nem ivott.. Mikor apa hazajött az éjjel, akkor meg inni

Protected

N/A

3
0
0
2022
Bredov, V. – Levin, A.: A lakossági kereslet előrejelzési módszereinek tökéletesítéséről

Emellett azonban egy sor olyan tényezőt is figyelembe kell venni, amely a lakossági ke- * resletre csak viszonylag hosszabb interval—. lumokban van hatással. llyen a városi és

Protected

N/A

1
0
0
2022
MAGYAR ONKOLÓGIA

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert C onsensus on the Primary Therapy of Early Breast Cancer. The

Protected

N/A

20
0
0
2022
Murine Breast Cancer Model

We show here that ASC.B6- derived factors induce Akt phosphorylation, hence switch on the PI3K/Akt signaling pathway, and thereby promote cell survival, proliferation, growth

Protected

N/A

8
0
0
2022
Journal of Breast Cancer

(A) An intracystic papillary component (right) is surrounded by a thick fibrous capsule and an invasive carcinoma (left) component on the low-power view of the lesion (H&E

Protected

N/A

4
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!